COSMOS Pharmaceutical Corporation - Strategy, SWOT and Corporate Finance Report
SynopsisCOSMOS Pharmaceutical Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Summary
- Detailed information on COSMOS Pharmaceutical Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting COSMOS Pharmaceutical Corporation in the form of a SWOT analysis
- An in-depth view of the business model of COSMOS Pharmaceutical Corporation including a breakdown and examination of key business segments
- Intelligence on COSMOS Pharmaceutical Corporation's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about COSMOS Pharmaceutical Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons To Buy
- Gain understanding of COSMOS Pharmaceutical Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess COSMOS Pharmaceutical Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on COSMOS Pharmaceutical Corporation's business structure, strategy and prospects.
Key Highlights
COSMOS Pharmaceutical Corporation (Cosmos) is a retail chain business of pharmaceutical products based in Japan. The company sells a range of drugs and cosmetic products. Its portfolio of products includes general self medication products, tonic drinks, oral care products, prescription medicines, nursing care products and vitamin supplements. It offers cosmetic products under the brand, Anterije. In addition, it offers health food products, daily food products, diet food, alcoholic beverages, cigarettes, confectionery and seasonings. Furthermore, the company offers miscellaneous goods such as baby products, clothing items, detergents, insecticides, toiletries, cookware, gardening goods, automobile goods and deodorizers. The company also provides product consulting services. It has a presence mainly in four districts such as Konsai, China, Shikoku and Kyushu. Cosmos is headquartered in Fukuoka, Japan.
In FY2014, the company opened 72 new stores across Japan.
Cosmos Pharmaceutical is engaged in the operation of a chain of drug stores "Discount Drug Cosmos." Co. maintains 827 stores in Kansai, Chugoku, Shikoku and Kyushu regions as of May 31 2017. Co.'s principal products are medicine, oral care products, nursing care products, dietary supplements, nutritional food products, cosmetics, hair care products, bath and body products, baby products, detergent, insecticides, toiletries, gardening products, automobile accessories, clothing, processed food products, dairy food products, snacks, non-alcohol and alcohol beverages, and cigarettes.
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.